Monitoring Medicines

Optimizing drug safety monitoring to enhance patient safety and achieve better health outcomes

back home
Print version Increase text Decrease text
Contract/Grant agreement number
: 223566
EC contribution
: € 1,995,096.00
: 42 months
Starting date
: 01/09/2009
: Pharmacovigilance, Patient safety, Adverse Drug Reactions, Safe medicines, Consumer reporting, Medication errors, Substandard medicines
Project web-site

Pharmacovigilance identifies and quantifies the risks of medicines use by analysing reports of adverse drug reactions and other adverse events, such as medication errors, and considers them within the context of their effectiveness. Although existing pharmacovigilance systems and activities are useful in identifying patient safety issues, there is considerable scope for optimizing and improving their use, particularly through wider inclusion of stakeholders in reporting of adverse drug reactions, promotion of harmonized reporting systems and broader application of data gathered on adverse drug reactions.

[+] Read More